A detailed history of Farther Finance Advisors, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 70 shares of ARCT stock, worth $1,121. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70
Previous 69 1.45%
Holding current value
$1,121
Previous $1.63 Million 0.49%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$18.08 - $25.38 $18 - $25
1 Added 1.45%
70 $1.63 Million
Q2 2024

Jul 31, 2024

BUY
$24.35 - $44.39 $438 - $799
18 Added 35.29%
69 $1.63 Million
Q4 2023

Feb 14, 2024

BUY
$17.71 - $32.97 $903 - $1,681
51 New
51 $1.61 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $426M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.